Hyphens Pharma International Ltd. (SG:1J5) has released an update.
Hyphens Pharma International Ltd. announces the resignation of Mr. Timothy Chen, CEO of DocMed Technology and Pan-Malayan Pharmaceuticals, effective from June 6, 2024. During his tenure, Chen significantly expanded the company’s digital health tech arm and online pharmaceutical hypermart across Singapore, Malaysia, and Vietnam. Hyphens Pharma’s CEO expressed gratitude for Chen’s contributions and wished him success in his future endeavors.
For further insights into SG:1J5 stock, check out TipRanks’ Stock Analysis page.
